Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

The National Institutes of Health reports that 80% of the American population will encounter lower back pain at some stage in their lives. The lower back is responsible for stabilizing and supporting ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of Dermatology/National Psoriasis ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

How Does Psoriasis Increase Your Risk of Developing Other Conditions? Psoriasis is much more than a skin condition. Though it ...

Adults who walked more than 100 minutes per day were less likely to have chronic low back pain than those who walked fewer than 78 minutes per day.

Psoriasis is a chronic autoimmune condition that mainly affects the skin. When you have psoriasis, your immune system sends ...

Normally, skin cells take about a month to form and rise to the surface. In people with psoriasis, this process happens in ...

Low testosterone and limited sleep emerged as key, independent contributors to psoriasis risk, revealing modifiable targets ...

IFPA (2021) International Federation of Psoriasis Associations - 6th World Psoriasis & Psoriatic Arthritis Conference. Mease PJ, et al. Efficacy and Safety of Deucravacitinib, an Oral, Selective ...